Warren, New Jersey — August 6, 2025 — Leads & Copy — Tevogen (Nasdaq: TVGN) announced an increase in institutional ownership of its outstanding common stock, based on Form 13F filings with the SEC.
Institutional ownership rose by 60% as of March 31, 2025, compared to December 31, 2024. Vanguard and BlackRock increased their holdings by 151%. Among 51 institutional investment managers, 73% increased or maintained their positions.
Tapan Shah, Tevogen’s Head of Investor Relations, noted that increased institutional ownership indicates confidence in the company’s fundamentals and growth potential. He cited Tevogen.AI advancements, patent activity, collaboration with Microsoft and Databricks, and plans for a GMP cell manufacturing facility.
The company will provide another update following the next SEC reporting period.
Contact: Tevogen Bio Communications, T: 1 877 TEVOGEN, Ext 701, Communications@Tevogen.com
Source: Tevogen Bio Holdings Inc.
